The reported side effects appear to be similar to those reported with sermorelin [6]
Furthermore, incretin-based therapies can also improve mitochondrial function and reduce apoptosis by increasing anti-apoptotic protein Bcl-2 expression and lowering pro-apoptotic BAX signaling, thereby promoting neuronal survival in dopaminergic cell lines ( GLP-1 receptor agonists (e.g., exenatide, liraglutide, lixisenatide) and dual GLP-1/GIP agonists (e.g., tirzepatide) have been also reported to reduce microglial and astrocytic hyperactivation and suppress the release of inflammatory mediators such as TNF-, IL-1, and NF-B
Promotes liver health to support your bodys natural detox processes
Delilah Health leads this evolution with its clinically backed GLP-1 program built for ambitious women, combining personalization, technology, and transparent support structures
Elderly patients (65+ years) or those on multiple medications : risk of drug interactions and muscle mass loss requires careful management